Correlation Between Privia Health and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Privia Health and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Privia Health and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Privia Health Group and Unicycive Therapeutics, you can compare the effects of market volatilities on Privia Health and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Privia Health with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Privia Health and Unicycive Therapeutics.
Diversification Opportunities for Privia Health and Unicycive Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Privia and Unicycive is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Privia Health Group and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Privia Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Privia Health Group are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Privia Health i.e., Privia Health and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Privia Health and Unicycive Therapeutics
Given the investment horizon of 90 days Privia Health is expected to generate 8.41 times less return on investment than Unicycive Therapeutics. But when comparing it to its historical volatility, Privia Health Group is 2.33 times less risky than Unicycive Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 61.00 in Unicycive Therapeutics on September 24, 2024 and sell it today you would earn a total of 7.40 from holding Unicycive Therapeutics or generate 12.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Privia Health Group vs. Unicycive Therapeutics
Performance |
Timeline |
Privia Health Group |
Unicycive Therapeutics |
Privia Health and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Privia Health and Unicycive Therapeutics
The main advantage of trading using opposite Privia Health and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Privia Health position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Privia Health vs. Certara | Privia Health vs. HealthStream | Privia Health vs. National Research Corp | Privia Health vs. HealthEquity |
Unicycive Therapeutics vs. Fate Therapeutics | Unicycive Therapeutics vs. Sana Biotechnology | Unicycive Therapeutics vs. Caribou Biosciences | Unicycive Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |